随着减重药巨头诺和诺德重磅GLP-1类药物司美格鲁肽在中国的核心分子专利即将于3月到期，一大批中国本土的司美格鲁肽仿制药正在获批路上。据公开信息，目前国内市场上包括九源基因、丽珠集团、华东医药、齐鲁制药、正大天晴在内的十多家本土制药公司的司美格鲁肽仿制药有望在不久的将来上市，还有十余款处于三期临床，一场价格大战即将席卷。一位内分泌专家表示，随着更多仿制药的上市，减重药很快就会迎来“白菜价”时代。（第一财经）
Donald Trump's lengthy State of the Union address has been one of the top subjects for late night hosts this week, from Stephen Colbert to Jimmy Kimmel and Seth Meyers.
。关于这个话题，同城约会提供了深入分析
We do pay the cost for a copy, but that cost is almost completely
Eve Myles inspired by detective who solved 30-year cold case in new role
，详情可参考51吃瓜
"I did pretty well. I was quite shocked."
union alloc_header *h = x;h--;，推荐阅读Line官方版本下载获取更多信息